Literature DB >> 2241279

Response criteria for slow acting antirheumatic drugs.

.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2241279      PMCID： PMC1004246          DOI： 10.1136/ard.49.10.819

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

Review 1.  What should we hope to achieve when treating rheumatoid arthritis?

Authors:  D L Scott; T D Spector; T Pullar; B McConkey
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

2.  Can we develop simple response criteria for slow acting antirheumatic drugs?

Authors:  D L Scott; J E Dacre; A Greenwood; L Treasure; E C Huskisson
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

3.  What are the 'best' measurements for monitoring patients during short-term second-line therapy?

Authors:  J S Dixon; S Hayes; P D Constable; H A Bird
Journal:  Br J Rheumatol       Date:  1988-02

4.  How safe is it to give parenteral iron to a patient with rheumatoid arthritis (RA) and iron deficiency anaemia?

Authors:  P Merry; B Kidd; D R Blake
Journal:  Br J Rheumatol       Date:  1989-02

5.  Ranking of laboratory tests by consensus analysis.

Authors:  B S Bull; W C Levy; J C Westengard; M Farr; P F Smith; J F Apperley; P A Bacon; J Stuart
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

6.  Improving the response to gold or D-penicillamine by addition of sulphasalazine. A pilot study in 25 patients with rheumatoid arthritis.

Authors:  P T Dawes; T P Sheeran; P D Fowler; M F Shadforth
Journal:  Clin Exp Rheumatol       Date:  1987 Apr-Jun       Impact factor: 4.473

7.  Clinical judgment in rheumatoid arthritis. III. British rheumatologists' judgments of 'change in response to therapy'.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.